We observed that the frequency of both NKG2D and NKp46 activation receptors was decreased in MPN (Figure 6A), while the KIR2DL inhibitory receptor was increased when compared to controls (Figure 6B). The gene discussed is KIR2DL3; the disease is myeloproliferative disorder.